Shahbazyan Oriental Medicine is categorized under Health Services in Los Angeles, CA and active since 2009.
Shahbazyan Oriental Medicine was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6213990 by the NAICS.
If you are seeking more information, feel free to contact Narine Khachatrian at the company’s single location by writing to 1340 North Virgil Avenue, Los Angeles, California CA 90027 or by phoning (323) 669-8383. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Shahbazyan Oriental Medicine |
| Contact Person: | Narine Khachatrian |
| Address: | 1340 North Virgil Avenue, Los Angeles, California 90027 |
| Phone Number: | (323) 669-8383 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6213990 |
| Share This Business: |
Shahbazyan Oriental Medicine was started in 2009 to provide professional Health Services under the SIC code 8099 and NAICS code 6213990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Narine Khachatrian for inquiries that concern Shahbazyan Oriental Medicine by calling the company number (323) 669-8383, as your correspondence is most welcome. Additionally, the physical location of the single location of Shahbazyan Oriental Medicine can be found at the coordinates 34.09671,-118.28728 as well as the street address 1340 North Virgil Avenue in Los Angeles, California 90027.
For its online presence, you may visit Shahbazyan Oriental Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.